Y. Victoria Zhang, PhD, MBA, DABCC, FAACC
University of Rochester Medical Center
Vice Chair Clinical Enterprise Strategy
Chief of Clinical Chemistry Division
Associate Professor of Department of Pathology and Laboratory MedicineDr. Victoria Zhang joined the University of Rochester Medical Center faculty at the Department of Pathology and Laboratory Medicine after she finished her fellowship training at the Harvard Medical School in 2011. She is currently the chief of Clinical Chemistry division to cover the practices of the chemistry core laboratory, clinical mass spectrometry and toxicology lab as well as point of care services. Dr. Zhang has been serving as the Vice Chair for Clinical Enterprise of the Department since 2017. Dr. Zhang also obtained her MBA (master in business administration) from the Wharton School at the University of Pennsylvania. Dr. Zhang has been focusing on her academic efforts in clinical applications of mass spectrometry and its training and education and is the leading expert in this area. She spearheaded the effort in establishing a new division in AACC – the Mass Spectrometry and Separation Sciences (MSSS) division and served as the founding Chair to grow the division to the national leading resources for clinical mass spectrometry. Dr. Zhang is the faculty Chair of two online certificate programs for mass spectrometry and they are ranked the top 3 mostly subscribed AACC online programs. She has over 100 national and international podium presentations with over a dozen media reports and expert interviews. Dr. Zhang has organized over 50 international and national symposia, workshops and short courses, as well as standalone regional and national conferences in clinical mass spectrometry and clinical chemistry. She was asked to represent the AACC to deliver public comments regarding laboratory developed tests oversight issues to the FDA in 2016 and was invited as the sole official Clinical Chemist expert on the “Cancer Moonshot” APOLLO Project Technology Working Group. Among several other national and international leadership functions outside of clinical mass spectrometry, Dr. Zhang serves as the founding Faculty Chair for the AACC Global Lab Quality Initiative Asia-Pacific Working Group to spearhead the efforts in developing workshops and frameworks for sustainable support for the Asia Pacific region to improve quality in lab medicine. She was recently the Chair of the AACC COVID 19 serology testing to deliver a public statement to the community on this very important topic. |
Prof. Dr. sc. nat. Katharina M Rentsch
University Hospital Basel
Head of Laboratory Medicine, Head of Clinical Chemistry Labormedizin
Basel, SwitzerlandProf. Katharina Rentsch is head of laboratory medicine at the University Hospital in Basel, Switzerland which covers clinical chemistry, clinical immunology, hematology and microbiology. In 2011 she joined the University Hospital Basel as head of the clinical chemistry department. She is directly responsible for the therapeutic drug monitoring and clinical toxicology laboratory. Before, she worked for 23 years in the Institute for Clinical Chemistry at the University Hospital Zurich where she also had the direct responsibility for the therapeutic drug monitoring and clinical toxicology laboratory. Her academic career started at the ETH in Zurich, Switzerland. Now she is professor for Clinical Chemistry at the Medical Faculty of the University Basel. In 1998 Prof. Rentsch’s laboratory was the first clinical laboratory using LC-MS/MS in clinical routine in Switzerland. Since then she uses this analytical technique for her research focusing on therapeutic drug monitoring and clinical toxicology and has presented >100 talks at national and international conferences (including IATDMCT and AACC). Many students of pharmaceutical sciences and 7 PhD students graduated in her lab. In 2009-2011 one of the worldwide first LC-MS based screening methods for yet unknown compounds has been developed and validated in her laboratory to be used as screening method for patients entering the emergency room. She has served as member of the council of the IATDMCT for 12 years and has been in the organizing and/or scientific committee of several meetings of the IATDMCT. Since 2015 she is vice-president of the Society of Toxicological and Forensic Chemistry (GTFCh) in Germany. During 6 years Prof. Rentsch has been president of the Swiss Society of Clinical Chemistry and she is heading its working group on therapeutic drug monitoring and clinical chemistry for more than 20 years. |
